home · filing · 0001104659-24-001326
8-K
filed January 4, 2024, 6:59 PM ET
CIK 0001267602
leadership
confidence high
sentiment neutral
materiality 0.65
Alimera Sciences names Elliot Maltz CFO, grants 75,000-share inducement option
ALIMERA SCIENCES INC
Elliot Maltz appointed CFO effective Jan 2, 2024, replacing Russell Skibsted who departed Dec 31, 2023.
Maltz receives annual base salary of $350,000 and target bonus up to 40% of base salary.
Maltz granted inducement option for 75,000 shares at $4.32, vesting over 4 years with 25% after 1 year.
Skibsted's departure not due to any disagreement with management or accounting practices.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Russell Skibsted
Chief Financial Officer
ALIMERA SCIENCES INC
Effective 2023-12-31
Successor Elliot Maltz
Filed January 4, 2024, 6:59 PM ET
determined that Russell Skibsted’s last day of employment as the Chief Financial Officer of the Company was December 31, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Russell Skibsted departed as Chief Financial Officer at ALIMERA SCIENCES INC.
Action departure
Role Chief Financial Officer
Exact text from the filing
determined that Russell Skibsted’s last day of employment as the Chief Financial Officer of the Company was December 31, 2023.
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-24-001326
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.